Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 4 of 4 drugs
| No. | KEGG DRUG | DrugBank | 薬物名（臨床試験情報から抽出） | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
Glycerin
1. Glycerin
| 1件: Glycerin Glycerin | 2件: Bee venom Bee venom; Glycerol | - | - | 5件: 6 6, 13, 79, 316, 317 💬
| ||||||||||||||||||||||||||||||||||||||||||||
| 2 |
Bezafibrate
2. Bezafibrate
| 1件: Bezafibrate Bezafibrate | 1件: Bezafibrate Bezafibrate | 1件: PPARA PPARA 💬2. Bezafibrate
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor ac ... | 7件: 20 20, 93, 94, 160, 296, 316, 324 💬
| ||||||||||||||||||||||||||||||||||||||||||||
| 3 |
Levocarnitine
3. Levocarnitine
| 1件: Levocarnitine Levocarnitine | 4件: Carnitine Carnitine; L-Carnitine; Levocarnitine; Xyzal | - | - | 11件: 3 3, 5, 13, 53, 58, 86, 96, 97, 265, 298, 316 💬3. Levocarnitine
| ||||||||||||||||||||||||||||||||||||||||||||
| 4 |
Adomiparin
4. Adomiparin
| 1件: Heparin Heparin | 2件: Heparin Heparin; HEPARIN SODIUM | 1件: SERPINC1 SERPINC1 💬4. Adomiparin
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 11件: 47 47, 60, 70, 84, 107, 224, 226, 280, 299, 316, 317 💬4. Adomiparin
|